SCHEMBL6257571

SCHEMBL6257571

CCCCCCCCCCCCCCCc1cccc(OCCO)c1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 6/20 0.66
PPARG P37231 4/20 0.66
CNR1 P21554 1/20 0.58
CNR2 P34972 1/20 0.58
MEN1 O00255 1/20 0.57
USP2 O75604 1/20 0.57
ALDH1A1 P00352 1/20 0.57
LMNA P02545 1/20 0.57
CYP3A4 P08684 1/20 0.57
MAPK1 P28482 1/20 0.57
CASP1 P29466 1/20 0.57
KMT2A Q03164 1/20 0.57
SMN1; SMN2 Q16637 1/20 0.57
SLCO1B3 Q9NPD5 1/20 0.57
SLCO1B1 Q9Y6L6 1/20 0.57
GGPS1 O95749 2/20 0.54
CYP2D6 P10635 4/20 0.54
TSHR P16473 1/20 0.53
LPL P06858 1/20 0.51
LIPG Q9Y5X9 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11320800 1.00 PPARA (0.66) PPARAPPARGCNR1CNR2MEN1
SCHEMBL516144 0.94 PPARA (0.57) PPARAPPARGCNR1CNR2MEN1
SCHEMBL3025797 0.93 PPARA (0.64) PPARAPPARGCNR1CNR2MEN1
SCHEMBL11356804 0.92 MEN1 (0.71) PPARAPPARGCNR1CNR2MEN1
SCHEMBL11356287 0.92 MEN1 (0.71) PPARAPPARGCNR1CNR2MEN1
SCHEMBL8499622 0.91 PPARA (0.62) PPARAPPARGCNR1CNR2GGPS1
SCHEMBL17509796 0.91 PPARA (0.68) PPARAPPARGCNR1CNR2GGPS1
SCHEMBL17509791 0.91 PPARA (0.68) PPARAPPARGCNR1CNR2GGPS1
SCHEMBL17509781 0.91 PPARA (0.68) PPARAPPARGCNR1CNR2GGPS1
SCHEMBL17509804 0.91 PPARA (0.68) PPARAPPARGCNR1CNR2GGPS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005072776-A2 LIPOSOMAL FORMULATIONS OF THE ANTINEOPLASTIC AGENTS INSTYTUT FARMACEUTYCZNY (PL) 2005-08-11 WO disclosed